Furthermore, an increasing number of molecular subtypes have been defined in BLCA; basal and luminal subtypes are the most stably accepted subtypes and display the upregulation of KRT5, KRT6, or GATA3 genes, and it is well known that BLCA with basal subtypes predicts worse prognosis (5). The gene discussed is KRT5; the disease is bladder transitional cell carcinoma.